Enablex (Warner Chilcott (US), LLC)
Welcome to the PulseAid listing for the Enablex drug offered from Warner Chilcott (US), LLC. This Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Warner Chilcott (US), LLC |
NON-PROPRIETARY NAME: | darifenacin |
SUBSTANCE NAME: | DARIFENACIN HYDROBROMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2004-12-22 |
END MARKETING DATE: | 0000-00-00 |
Enablex HUMAN PRESCRIPTION DRUG Details:
Item Description | Enablex from Warner Chilcott (US), LLC |
LABELER NAME: | Warner Chilcott (US), LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 7.5(mg/1) |
START MARKETING DATE: | 2004-12-22 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0430-0170_b7d38a35-dc1c-4bdc-a32f-776289dc4158 |
PRODUCT NDC: | 0430-0170 |
APPLICATION NUMBER: | NDA021513 |
Other DARIFENACIN HYDROBROMIDE Pharmaceutical Manufacturers / Labelers: